The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

Alzheimer's and Dementia

Volumn 11, Issue 12, 2015, Pages 1407-1416

  Lill, Christina M ^a,b   Rengmark, Aina ^c   Pihlstrøm, Lasse ^c   Fogh, Isabella ^d   Shatunov, Aleksey ^d   Sleiman, Patrick M ^e,f   Wang, Li San ^f   Liu, Tian ^g   Lassen, Christina F ^h   Meissner, Esther ^b   Alexopoulos, Panos ⁱ   Calvo, Andrea ^j   Chio, Adriano ^j,k   Dizdar, Nil ^l   Faltraco, Frank ^m   Forsgren, Lars ⁿ   Kirchheiner, Julia ^o   Kurz, Alexander ⁱ   Larsen, Jan P ^p   Liebsch, Maria ^b   Linder, Jan ⁿ   Morrison, Karen E ^q,r   Nissbrandt, Hans ^s   Otto, Markus ^o   Pahnke, Jens ^a,t   Partch, Amanda ^f   Restagno, Gabriella ^u   Rujescu, Dan ^v   Schnack, Cathrin ^o   Shaw, Christopher E ^d   Shaw, Pamela J ^w   Tumani, Hayrettin ^o   Tysnes, Ole Bjørn ^x,y   Valladares, Otto ^f   Silani, Vincenzo ^z,aa   Van Den Berg, Leonard H ^ab   Van Rheenen, Wouter ^ab   Veldink, Jan H ^ab   Lindenberger, Ulman ^g   Steinhagen Thiessen, Elisabeth ^ac   Teipel, Stefan ^ad,ae   Perneczky, Robert ^i,af,ag   Hakonarson, Hakon ^e,f   Hampel, Harald ^ah,ai   Von Arnim, Christine A F ^o   Olsen, Jørgen H ^h   Van Deerlin, Vivianna M ^f   Al Chalabi, Ammar ^d   Toft, Mathias ^c   Ritz, Beate ^aj   Bertram, Lars ^a,b,af   more..

^a UNIVERSITY OF LÜBECK   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

^h INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j UNIVERSITY OF TURIN   (Italy)

^k National Institute of Neuroscience Turin   (Italy)

^l LINKÖPING UNIVERSITY   (Sweden)

^m GOETHE UNIVERSITY   (Germany)

ⁿ UMEÅ UNIVERSITY   (Sweden)

^o UNIVERSITY OF ULM   (Germany)

^p STAVANGER UNIVERSITY HOSPITAL   (Norway)

^q UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^r UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^s UNIVERSITY OF GOTHENBURG   (Sweden)

^t UNIVERSITY OF OSLO   (Norway)

^u Azienda Ospedaliera Città della Salute e della Scienza   (Italy)

^v MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^w UNIVERSITY OF SHEFFIELD   (United Kingdom)

^x HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^y UNIVERSITY OF BERGEN   (Norway)

^z ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^aa UNIVERSITY OF MILAN   (Italy)

^ab UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ac CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^ad GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^ae UNIVERSITY OF ROSTOCK   (Germany)

^af IMPERIAL COLLEGE LONDON   (United Kingdom)

^ag WEST LONDON MENTAL HEALTH NHS TRUST   (United Kingdom)

^ah AXA   (France)

^ai SORBONNE UNIVERSITÉ   (France)

^aj UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Alzheimer disease; Amyotrophic lateral sclerosis; Frontotemporal lobar degeneration; Genetic association; GWAS; Imputation; Meta analysis; Neurodegenerative disease; Parkinson disease; R47H; Rare variant; rs75932628; TREM2

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; TAU PROTEIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM2 PROTEIN, HUMAN;

ALLELE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; FRONTOTEMPORAL DEMENTIA; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; META ANALYSIS (TOPIC); MILD COGNITIVE IMPAIRMENT; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; AGED; CASE CONTROL STUDY; CAUCASIAN; DEGENERATIVE DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; MIDDLE AGED; QUANTITATIVE TRAIT LOCUS;

AGED; ALLELES; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; QUANTITATIVE TRAIT LOCI; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; TAU PROTEINS;

EID: 84952631227     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.12.009     Document Type: Article

References (44)

1. C.M. Lill, and L. Bertram Towards unveiling the genetics of neurodegenerative diseases Semin Neurol 31 2011 531 541
2. J.C. Lambert, C.A. Ibrahim-Verbaas, D. Harold, A.C. Naj, R. Sims, C. Bellenguez, and et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease Nat Genet 45 2013 1452 1458
3. M.A. Nalls, N. Pankratz, C.M. Lill, C.B. Do, D.G. Hernandez, M. Saad, and et al. Large scale meta analysis of genome-wide association data in Parkinson's disease reveals 6 novel risk loci Nat Genet 46 2014 989 993
4. V.M. Van Deerlin, P.M. Sleiman, M. Martinez-Lage, A. Chen-Plotkin, L.S. Wang, N.R. Graff-Radford, and et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions Nat Genet 42 2010 234 239
5. I. Fogh, A. Ratti, C. Gellera, K. Lin, C. Tiloca, V. Moskvina, and et al. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis Hum Mol Genet 23 2014 2220 2231
6. T. Jonsson, H. Stefansson, S. Steinberg, I. Jonsdottir, P.V. Jonsson, J Snaedal, and et al. Variant of TREM2 associated with the risk of Alzheimer's disease N Engl J Med 368 2013 107 116
7. R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, E Majounie, and et al. TREM2 variants in Alzheimer's disease N Engl J Med 368 2013 117 127
8. J. Paloneva, T. Manninen, G. Christman, K. Hovanes, J. Mandelin, R. Adolfsson, and et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype Am J Hum Genet 71 2002 656 662
9. R.J. Guerreiro, E. Lohmann, J.M. Brás, J.R. Gibbs, J.D. Rohrer, N. Gurunlian, and et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement JAMA Neurol 70 2013 78 84
10. B. Borroni, F. Ferrari, D. Galimberti, B. Nacmias, C. Barone, S. Bagnoli, and et al. Heterozygous TREM2 mutations in frontotemporal dementia Neurobiol Aging 35 2014
11. E. Cuyvers, K. Bettens, S. Philtjens, T. Van Langenhove, I. Gijselinck, J. van der Zee, and et al. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia Neurobiol Aging 35 2014 726.e11 726.e19
12. S. Rayaprolu, B. Mullen, M. Baker, T. Lynch, E. Finger, W.W. Seeley, and et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease Mol Neurodegener 8 2013 19
13. A. Ruiz, O. Dols-Icardo, M.J. Bullido, P. Pastor, E. Rodríguez-Rodríguez, A. López de Munain, and et al. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia Neurobiol Aging 35 2014 444.e1 444.e4
14. B.A. Benitez, C. Cruchaga United States-Spain Parkinson's Disease Research Group TREM2 and neurodegenerative disease N Engl J Med 369 2013 1567 1568
15. T. Jonsson, and K. Stefansson TREM2 and neurodegenerative disease N Engl J Med 369 2013 1568 1569
16. J. Cady, E.D. Koval, B.A. Benitez, C. Zaidman, J. Jockel-Balsarotti, P. Allred, and et al. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis JAMA Neurol 71 2014 449 453
17. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
18. L. Bertram, A. Böckenhoff, I. Demuth, S. Düzel, R. Eckardt, S.C. Li, and et al. Cohort profile: The Berlin Aging Study II (BASE-II) Int J Epidemiol 43 2013 703 712
19. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308
20. R.G. Miller, T.L. Munsat, M. Swash, and B.R. Brooks Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research J Neurol Sci 169 1999 2 12
21. K. Rugbjerg, B. Ritz, L. Korbo, N. Martinussen, and J.H. Olsen Risk of Parkinson's disease after hospital contact for head injury: population based case-control study BMJ 337 2008 a2494
22. A.J. Hughes, S.E. Daniel, L. Kilford, and A.J. Lees Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 1992 181 184
23. D.J. Gelb, E. Oliver, and S. Gilman Diagnostic criteria for Parkinson disease Arch Neurol 56 1999 33 39
24. E. Khurana, Y. Fu, V. Colonna, X.J. Mu, H.M. Kang, T. Lappalainen, and et al. Integrative annotation of variants from 1092 humans: application to cancer genomics Science 342 2013 1235587
25. B.M.M. Schjeide, C. Schnack, J.C. Lambert, C.M. Lill, J. Kirchheiner, H. Tumani, and et al. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels Arch Gen Psychiatry 68 2011 207 213
26. S. Sawcer Bayes factors in complex genetics Eur J Hum Genet 18 2010 746 750
27. L. Broer, C.M. Lill, M. Schuur, N. Amin, J.T. Roehr, L. Bertram, and et al. Distinguishing true from false positives in genomic studies: p values Eur J Epidemiol 28 2013 131 138
28. L. Bertram, M.B. McQueen, K. Mullin, D. Blacker, and R.E. Tanzi Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nat Genet 39 2007 17 23
29. C.M. Lill, J.T. Roehr, M.B. McQueen, F.K. Kavvoura, S. Bagade, B.M. Schjeide, and et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database PLoS Genet 8 2012 e1002548
30. C. Slattery, J.A. Beck, L. Harper, G. Adamson, Z. Abdi, J. Uphill, and et al. R47H TREM2 variants increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia Alzheimers Dement 10 2014 602 608.e4
31. M. Giraldo, F. Lopera, A.L. Siniard, J.J. Corneveaux, I. Schrauwen, J. Carvajal, and et al. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease Neurobiol Aging 34 2013 2077.e11 2077.e18
32. B.A. Benitez, B. Cooper, P. Pastor, S.C. Jin, E. Lorenzo, S. Cervantes, and et al. TREM2 is associated with the risk of Alzheimer's disease in Spanish population Neurobiol Aging 34 2013 1711.e15 1711.e17
33. L. Bertram, A.R. Parrado, and R.E. Tanzi TREM2 and neurodegenerative disease N Engl J Med 369 2013 1565
34. J.D. Gonzalez Murcia, C. Schmutz, C. Munger, A. Perkes, A. Gustin, M. Peterson, and et al. Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study Neurobiol Aging 34 2013 2889.e11 2889.e13
35. C. Pottier, D. Wallon, S. Rousseau, A. Rovelet-Lecrux, A.C. Richard, A. Rollin-Sillaire, and et al. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease J Alzheimers Dis 35 2013 45 49
36. R.M. Harbord, M. Egger, and J.A. Sterne A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints Stat Med 25 2006 3443 3457
37. T. Pfeiffer, L. Bertram, and J.P. Ioannidis Quantifying selective reporting and the Proteus phenomenon for multiple datasets with similar bias PLoS One 6 2011 e18362
38. B.V. Hooli, A.R. Parrado, K. Mullin, W.K. Yip, T. Liu, J.T. Roehr, and et al. The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk Neurology 83 2014 1353 1358
39. C. Cruchaga, J.S. Kauwe, O. Harari, S.C. Jin, Y. Cai, C.M. Karch, and et al. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease Neuron 78 2013 256 268
40. N. Zilka, Z. Kazmerova, S. Jadhav, P. Neradil, A. Madari, D. Obetkova, and et al. Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways J Neuroinflammation 9 2012 47
41. J.-T. Yu, T. Jiang, Y.L. Wang, H.F. Wang, W. Zhang, N. Hu, and et al. Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer's disease in Han Chinese individuals Neurobiol Aging 35 2014 937.e1 937.e3
42. A. Miyashita, Y. Wen, N. Kitamura, E. Matsubara, T. Kawarabayashi, M. Shoji, and et al. Lack of genetic association between TREM2 and late-onset Alzheimer's disease in a Japanese population J Alzheimers Dis 41 2014 1031 1038
43. C. Reitz, R. Mayeux Alzheimer's Disease Genetics Consortium TREM2 and neurodegenerative disease N Engl J Med 369 2013 1564 1565
44. R.E. Kennedy, G.R. Cutter, and L.S. Schneider Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease Alzheimers Dement 10 2014 349 359